🇺🇸 FDA

Drug profile · INN

methylphenidate hydrochloride

TUZULBY

approved N06BA04
US status
approved
Patents linked
0
News articles
0

Quick answer

methylphenidate hydrochloride (TUZULBY) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN methylphenidate hydrochloride
Brand TUZULBY
Route ORAL
Formulation TABLET, EXTENDED RELEASE
ATC code N06BA04

Frequently asked questions

What is methylphenidate hydrochloride?

methylphenidate hydrochloride (TUZULBY) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for methylphenidate hydrochloride?

TUZULBY is a marketed brand name for methylphenidate hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of methylphenidate hydrochloride?

methylphenidate hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.